Askel Healthcare
2021
Askel Healthcare created COPLA®, a regenerative implant for cartilage repair, aiming to restore joint function and avoid prosthetic surgery in orthopaedic patients.
Website
More details...
Company Overview
CEO
Virpi Muhonen
INVESTED IN
2021
SECTOR
Medtech
Why we invested
- High barrier to entry as COPLA is a Class III medical device
- Strong and defensible IP protecting the core technology
- Very robust preclinical and Phase I clinical results
- Addresses a large orthopaedic market with limited regenerative solutions
- High potential reward profile with clear value inflection points